This concept gains support from existing research, where IL-38 expression was significantly associated with CD8+ tumour-infiltrating lymphocytes in lung cancer (28), and IL-38 was shown to potentially impact the further differentiation of CD4+ T cells (29). The gene discussed is CD4; the disease is lung carcinoma.